AMIX
NASDAQ HealthcareAutonomix Medical, Inc. - Common Stock
Medical Devices
Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders of nervous system. The company's technology platform includes a catheter-based system incorporating microchip-enabled sensing architecture designed to detect low-amplitude neural signals from within the vascular system. It develops technology for patients with pancreatic cancer and addresses indications for chronic pain management, hypertension, cardiovascular, and other nerve-related disorders. Autonomix Medical, Inc. was incorporated in 2014 and is headquartered in The Woodlands, Texas.
๐ Market Data
| Price | $6.40 |
|---|---|
| Volume | 122,622 |
| Market Cap | 3.48M |
| RSI (14-Day) | 55.7 |
| 200-Day MA | $10.05 |
| 50-Day MA | $6.81 |
| 52-Week High | $32.55 |
| 52-Week Low | $2.44 |
| Forward P/E | -0.86 |
| Price / Book | 1.10 |
๐ฏ Investment Strategy Scores
AMIX scores across each investment strategy. Higher is better for that strategy's goals.
๐ Strategy Interpretation
Best fit: ๐ช Falling Knife (95/100) โ this strategy Contrarian plays (oversold + below moving average).
Lowest fit among scored strategies: ๐ Moon Shot (10/100). No single score is a buy or sell signal โ use multiple lenses together. Learn how to read these scores โ
๐ Learn More
Indicators on this page
Educational articles
Find AMIX in your text
Paste any article, transcript, or post โ the tool will extract AMIX and every other hidden ticker.
Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.
Data last updated: 2026-08-17.